Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-7,500
Closed -$6.25M 23
2016
Q2
$6.25M Hold
7,500
0.33% 19
2016
Q1
$6.89M Hold
7,500
0.45% 18
2015
Q4
$7.72M Hold
7,500
0.35% 22
2015
Q3
$7.08M Hold
7,500
0.35% 21
2015
Q2
$7.84M Buy
+7,500
New +$7.85M 0.33% 24

Other funds holding AGN.PRA

Three Bays Capital's AGN.PRA Position: Q3 2016 in Review

Three Bays Capital sold out of Allergan plc (AGN.PRA) in Q3 2016, closing a stake of 7,500 shares — an estimated $6.25M sold.

Three Bays Capital first reported a position in AGN.PRA in Q2 2015 and held it in 5 quarters. The position peaked at $7.84M in Q2 2015. 117 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2016.

  • Three Bays Capital reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Three Bays Capital sold 7,500 Allergan plc shares in Q3 2016, an estimated $6.25M.
  • Three Bays Capital first reported a position in Allergan plc in Q2 2015 and held it in 5 quarters.
  • Three Bays Capital's Allergan plc position peaked at $7.84M in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Three Bays Capital's 13F filing for Q3 2016, filed 14 Nov 2016.